Shots: Biogen acquires Nightstar Therapeutics, in all stock transaction with its lead candidates NSR-REP1 & NSR-RPGR. Nightstar Therapeutics to receive $25.50 /share in cash for one day premium of 68% […]readmore
Tags : NSR-REP1